Cellectar Biosciences, Inc. (CLRB) — Institutional Holders, Q2 2026
29 institutional investment managers reported a CLRB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $9.1M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CLRB in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Caligan PartnersNew · +469,998 sh+$1.3M
- StemPoint CapitalNew · +354,938 sh+$986.7K
- SILVERARC CAPITAL MANAGEMENTNew · +321,728 sh+$894.4K
- BALYASNY ASSET MANAGEMENT L.P.New · +220,000 sh+$611.6K
- Nantahala Capital ManagementNew · +219,998 sh+$611.6K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -52,205 sh-$145.1K
- Warberg Asset ManagementSold out · -27,800 sh-$77.3K
- UBS Group AGTrimmed · -16,201 sh-$45.0K
- Sequoia Financial AdvisorsTrimmed · -15,850 sh-$44.1K
- Riverview Capital AdvisersTrimmed · -10,384 sh-$28.9K
CLRB 13F holders ranked 1–29 of 29
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Caligan Partners#1 · 469,998 sh | 469,998 | $1.3M | 0.06% | New |
| 2 | StemPoint Capital#2 · 354,938 sh | 354,938 | $986.7K | 0.17% | New |
| 3 | VANGUARD CAPITAL MANAGEMENT#3 · 327,367 sh | 327,367 | $910.1K | 0.00% | +299.8% |
| 4 | SILVERARC CAPITAL MANAGEMENT#4 · 321,728 sh | 321,728 | $894.4K | 0.09% | New |
| 5 | Bleichroeder#5 · 288,679 sh | 288,679 | $802.5K | 0.14% | +188.7% |
| 6 | Jupiter Topco#6 · 274,156 sh | 274,156 | $759.4K | <0.01% | — |
| 7 | BALYASNY ASSET MANAGEMENT L.P.#7 · 220,000 sh | 220,000 | $611.6K | <0.01% | New |
| 8 | Nantahala Capital Management#8 · 219,998 sh | 219,998 | $611.6K | 0.02% | New |
| 9 | Empery Asset Management#9 · 189,605 sh | 189,605 | $527.1K | 0.61% | New |
| 10 | DIADEMA PARTNERS#10 · 138,341 sh | 138,341 | $384.6K | 0.05% | New |
| 11 | Stonepine Capital Management#11 · 104,550 sh | 104,550 | $290.6K | 0.14% | New |
| 12 | Persistent Asset Partners Ltd#12 · 92,983 sh | 92,983 | $258.5K | 0.08% | New |
| 13 | BOOTHBAY FUND MANAGEMENT#13 · 85,069 sh | 85,069 | $236.5K | <0.01% | New |
| 14 | GEODE CAPITAL MANAGEMENT#14 · 53,351 sh | 53,351 | $148.3K | 0.00% | +1.1% |
| 15 | VANGUARD FIDUCIARY#15 · 46,220 sh | 46,220 | $128.5K | 0.00% | +178.9% |
| 16 | Sequoia Financial Advisors#16 · 21,850 sh | 21,850 | $60.7K | <0.01% | +15.9% |
| 17 | Riverview Capital Advisers#17 · 10,384 sh | 10,384 | $50.1K | 0.01% | 0.0% |
| 18 | ACADIAN ASSET MANAGEMENT#18 · 16,577 sh | 16,577 | $46.0K | <0.01% | New |
| 19 | NORTHERN#19 · 14,839 sh | 14,839 | $41.3K | 0.00% | New |
| 20 | BlackRock#20 · 4,735 sh | 4,735 | $13.2K | 0.00% | -0.2% |
| 21 | UBS Group AG#21 · 3,093 sh | 3,093 | $8.6K | 0.00% | -67.9% |
| 22 | BARCLAYS PLC#22 · 561 sh | 561 | $1.6K | 0.00% | New |
| 23 | MORGAN STANLEY#23 · 510 sh | 510 | $1.4K | 0.00% | 0.0% |
| 24 | TD Waterhouse Canada#24 · 63 sh | 63 | $178.00 | — | 0.0% |
| 25 | SBI Securities , Ltd.#25 · 11 sh | 11 | $31.00 | — | 0.0% |
| 26 | OSAIC#26 · 7 sh | 7 | $18.00 | 0.00% | +600.0% |
| 27 | US BANCORP \DE\#27 · 3 sh | 3 | $8.00 | 0.00% | 0.0% |
| 28 | JONES FINANCIAL COMPANIES LLLP#28 · 3 sh | 3 | $8.00 | 0.00% | 0.0% |
| 29 | DANSKE BANK A/S#29 · 2 sh | 2 | $6.00 | 0.00% | 0.0% |
Funds that sold out of CLRB in Q2 2026 (4)
Held CLRB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Warberg Asset Management27,800 sh | 27,800 | $35.3K |
| Tower Research Capital (TRC)1,586 sh | 1,586 | $2.0K |
| Vanguard Global Advisers1,126 sh | 1,126 | $1.4K |
| FMR20 sh | 20 | $25.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.